Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
Top Cited Papers
Open Access
- 1 May 2004
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 126 (5), 1287-1292
- https://doi.org/10.1053/j.gastro.2004.02.015
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Medical Management of Hyperlipidemia/DyslipidemiaJournal of Clinical Endocrinology & Metabolism, 2003
- Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairmentEuropean Journal of Clinical Pharmacology, 2003
- Safety considerations for statinsCurrent Opinion in Lipidology, 2002
- Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic DrugsSeminars in Liver Disease, 2002
- Lipid lowering medication and hepatotoxicityJournal of Internal Medicine, 2001
- Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trialJournal of Hepatology, 2001
- The Regenstrief Medical Record System: a quarter century experienceInternational Journal of Medical Informatics, 1999
- Acute Cholestatic Hepatitis Associated With PravastatinThe American Journal of Gastroenterology, 1999
- Ator vastatin-induced acute hepatitis with absence of cross-toxicity with simvastatinThe Lancet, 1999
- Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatinDigestive Diseases and Sciences, 1994